Infantile nucleated red blood cell trap vector, extraction device and method

A nuclear red blood cell and extraction device technology, which is applied in the field of biomedical materials, can solve problems such as difficulty in meeting actual clinical needs, limited effective binding amount, and affecting detection sensitivity, etc., and achieves strong detection sensitivity and specificity, and the source of raw materials is not affected. The effect of good protection

CN111893086AActive Publication Date: 2020-11-06SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI
3 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2020-11-06

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an infantile nucleated red blood cell trap vector, an extraction device and a method. The infantile nucleated red blood cell trap vector is obtained by coupling a protein spinning membrane murine monoclonal antibody and a nucleated red blood cell marker murine monoclonal antibody on a protein spinning membrane. The scheme can specifically trap a nucleated red blood cell, has the characteristics of strong detection sensitivity and specificity and overcomes the defects of non-specific binding, disordered coating and low efficiency of a traditional method; the protein spinning membrane has a multi-layer porous structure, has the surface area bound with a reactor far larger than that of an existing vector, and is extremely weakly bound with non-specific ingredients in ablood sample; and furthermore, protein ingredients of the protein spinning membrane have an excellent protective effect on bound bio-active ingredients and have good stability. The extraction deviceis simple in structure and easy in preparation, is not limited by raw material source and has low cost. The extraction method is easy to operate and can avoid loss of cells in the operating process.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of biomedical materials, in particular to a fetal nucleated red blood cell capture carrier, extraction device and method. Background technique

[0002] Fetal nucleated red blood cells are a kind of mononuclear cells, which exist continuously and stably in the peripheral blood of the mother from the first trimester to before delivery, containing all the genetic information of the fetus, with specific antigens on the cell surface, and a short life cycle. Prenatal testing is not affected by previous pregnancy, so fetal nucleated red blood cells are considered to be the most ideal fetal-derived cells for non-invasive prenatal diagnosis. However, the content of fetal nucleated red blood cells in maternal peripheral blood is very small, so the high-efficiency and high-purity enrichment of fetal nucleated red blood cells for clinical detection is the focus of research.

[0003] The traditional separation and enrichment meth...

Examples

preparation example Construction

[0042] The preparation method of the fetal nucleated red blood cell capture carrier includes the following steps: preparing protein spinning membrane mouse monoclonal antibody and fetal nucleated red blood cell marker mouse monoclonal antibody, and then bridging the two through anti-mouse secondary antibody to obtain A reaction carrier capable of capturing fetal nucleated red blood cells: the fetal nucleated red blood cell capture carrier.

[0043]In the present invention, the natural biological material is processed and modified to prepare a protein spinning membrane with immunogenicity and good hydrophilicity, and then the reaction carrier capable of specifically capturing fetal nucleated red blood cells is obtained through anti-mouse secondary antibody bridging antibody , which overcomes the disadvantages of non-specific binding, disordered coating and low efficiency of traditional methods. In addition, the protein spinning membrane has a multi-layer pore structure, and the...

Embodiment 1

[0047] The preparation of protein spinning membrane, it may further comprise the steps:

[0048] 1. Protein spinning

[0049] Plant protein silk, animal protein silk and insect silk are frozen and ground into ultra-short silk or powder, adding a small amount of polyethylene terephthalate (PET), fully mixed, spinning and doffing and drafting to form a protein spun mesh with a pore size of 50 μm to 100 μm.

[0050] 2. Machining

[0051] Cut the protein spinning mesh into squares of the same size, and lay them vertically to form a non-woven fabric substrate; spray water mist evenly, place the non-woven fabric substrate in the middle of a hot-pressing plate, and perform vertical hot-pressing to form a pore size of 50 μm~ Protein spinning membrane of 100μm, thickness 0.2mm±0.02mm, porosity 1%~3%.

[0052] 3. Assay of protein spinning membrane

[0053] The pore size, thickness and porosity of the protein spinning membrane were tested, and the specific monoclonal antibody was use...

Embodiment 2

[0055] The preparation of mouse monoclonal antibody (protein spinning membrane mouse monoclonal antibody and fetal nucleated erythrocyte marker mouse monoclonal antibody) comprises the following steps:

[0056] 1. Mice Immunization

[0057] Prepare protein spinning membrane antigen and fetal nucleated erythrocyte markers respectively. After emulsification, mice are immunized at multiple points through the abdominal cavity and back subcutaneously. A total of 4 times are immunized with an interval of 10 days; immunity.

[0058] 2. Cell Fusion

[0059] Take the spleen of the immunized mouse, prepare the spleen cell suspension, and mix the mouse spleen cells with the cultured NS1 myeloma cells; use 50% PEG 4000 as the fusion agent, and combine the mouse spleen cells with the NS1 myeloma cells Fusion; Fused cells were suspended in selection medium containing 20% ​​newborn bovine serum and cultured for several days.

[0060] 3. Clonal Screening

[0061] The protein spinning memb...